![H. Moses Murdock: How I Treat AML relapse after allogeneic HCT](https://oncodaily.com/pub/uploads/2025/01/sdss-1280x720.jpg)
H. Moses Murdock, Mahasweta Gooptu and Robert Soiffer
Jan 10, 2025, 23:34
H. Moses Murdock: How I Treat AML relapse after allogeneic HCT
H. Moses Murdock, Hematology/Oncology fellow at Dana-Farber Cancer Institute, shared a post on X about a recent review article by him and colleagues, published in Blood:
“Excited to share our new manuscript co-authored by Dana-Farber Cancer Institute BMT mentors Dr. Gooptu and Dr. Soiffer: How I Treat AML relapse after allogeneic HCT.
No one-size-fits-all approach to this challenging situation learned a ton writing it!”
“How I Treat AML relapse after allogeneic HCT”
![H. Moses Murdock: How I Treat AML relapse after allogeneic HCT 1 H. Moses Murdock: How I Treat AML relapse after allogeneic HCT](https://oncodaily.com/pub/uploads/2025/01/Screenshot-2025-01-10-at-16.44.43-800x221.png)
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 10, 2025, 11:18
Feb 10, 2025, 10:52
Feb 10, 2025, 10:45
Feb 10, 2025, 10:04